Stockreport

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology [Yahoo! Finance]

Femasys Inc.  (FEMY) 
PDF - FemBloc is being developed as a first-of-its-kind, non-surgical permanent birth control with a clear U.S. regulatory pathway - ATLANTA, Jan. 23, 2024 (GLOBE NEWSWIR [Read more]